Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leiomyoma 5 Breast Neoplasms 4 Prostatic Neoplasms 3 Pituitary Diseases 3 Pituitary ACTH Hypersecretion 3 Cushing Syndrome 3 ACTH Syndrome, Ectopic 3 Ovarian Neoplasms 2 Hirsutism 2 Fallopian Tube Neoplasms 2 Choristoma 2 Carcinoma, Ovarian Epithelial 2 Breast Neoplasms, Male 2 Adrenal Cortex Neoplasms 2 Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 1 Uterine Hemorrhage 1 Sarcoma 1 Meningioma 1 Endometrial Stromal Tumors 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Hydroxyurea 4 aldesleukin 3 Magnetic Resonance Spectroscopy 3 Imatinib Mesylate 3 Everolimus 3 Temozolomide 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Conformal 2 Psychiatric Rehabilitation 2 Proton Therapy 2 Paclitaxel 2 Laser Speckle Contrast Imaging 2 Filgrastim 2 Donepezil 2 Cyclophosphamide 2 Carmustine 2 Bortezomib 2 Bevacizumab 2 Aminolevulinic Acid 2 90Y-octreotide, DOTA-Tyr(3)- 2 vistusertib 1 vatalanib 1 trametinib 1 tozuleristide 1 temsirolimus 1 sonidegib 1 sargramostim 1 ribociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Meningioma × Mifepristone × Clear all

NCT03015701 2019-12-23

S9005 Mifepristone in Meningioma

SWOG Cancer Research Network

Phase 3 Completed

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡